“Safety and Efficacy of Combination Therapy of Upadacitinib and Biologic Agents for Treatment-Resistant Psoriasis and Psoriatic Arthritis”, J of Skin, vol. 8, no. 3, pp. 1574–1580, May 2024, doi: 10.25251/skin.8.3.17.